Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Medical Devices

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Comment by elgin1on Jan 16, 2018 3:13pm

73 Views

Post# 27370475

RE:RE:RE:RE:RE:RE:ViaCyte Trial

The initial clinical trial for Sva will be using immunosuppression drugs as well. We do know that Sva device did not cause fibrosis, and produced insulin cells. We do know that Viacyte caused fibosis and their progenitor cells died. Both used immuno-suprresion drugs.

Question for you www.... is this a modified version of thier initial device? Must be just dont see reason for using their failed device in a clinical trial again. They are waiting two years for results... that seems odd.

Anyways will get interesting for sure....

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features